Are trans -complementation systems suitable for hepatitis C virus life cycle studies?
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs
Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B
A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network
Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D
Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells–associated hepatitis C virus RNA in chronically infected patients
Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C
IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication
Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population
Towards realistic estimates of HCV incidence in Egypt
PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection
Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes
Chronic hepatitis B virus (HBV) infection in children
Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replication
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Reliability, validity and sensitivity of the Chinese (simple) Short Form 36 Health Survey version 2 (SF-36v2) in patients with chronic hepatitis B
In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes
Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co-ordinate infectious virus production
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome
Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up
Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin
Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C
Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates
Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C
Dissimilar expression of multidrug resistance mdr1 and bcrp by the replication of hepatitis C virus
Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT
Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area
Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in India